Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase
Open Access
- 30 November 2018
- journal article
- conference paper
- Published by Springer Nature in BMC Bioinformatics
- Vol. 19 (S15) , 39-46
Abstract
Severity gradation of missense mutations is a big challenge for exome annotation. Predictors of deleteriousness that are most frequently used to filter variants found by next generation sequencing, produce qualitative predictions, but also numerical scores. It has never been tested if these scores correlate with disease severity. wANNOVAR, a popular tool that can generate several different types of deleteriousness-prediction scores, was tested on Fabry disease. This pathology, which is caused by a deficit of lysosomal alpha-galactosidase, has a very large genotypic and phenotypic spectrum and offers the possibility of associating a quantitative measure of the damage caused by mutations to the functioning of the enzyme in the cells. Some predictors, and in particular VEST3 and PolyPhen2 provide scores that correlate with the severity of lysosomal alpha-galactosidase mutations in a statistically significant way. Sorting disease mutations by severity is possible and offers advantages over binary classification. Dataset for testing and training in silico predictors can be obtained by transient transfection and evaluation of residual activity of mutants in cell extracts. This approach consents to quantitative data for severe, mild and non pathological variants.Keywords
This publication has 71 references indexed in Scilit:
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov ModelsHuman Mutation, 2012
- The Molecular Basis of Pharmacological Chaperoning in Human α-GalactosidaseChemistry & Biology, 2011
- A pharmacogenetic approach to identify mutant forms of α‐galactosidase a that respond to a pharmacological chaperone for Fabry diseaseHuman Mutation, 2011
- Single-nucleotide evolutionary constraint scores highlight disease-causing mutationsNature Methods, 2010
- Catalytic Mechanism of Human α-GalactosidaseJournal of Biological Chemistry, 2010
- Functional studies of new GLA gene mutations leading to conformational fabry diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Identifying novel constrained elements by exploiting biased substitution patternsBioinformatics, 2009
- Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and StabilityBiochemistry, 2009
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*The American Journal of Human Genetics, 2006